DHEA therapy for women: Effect on sexual function and wellbeing

Human Reproduction Update

Volumn 13, Issue 3, 2007, Pages 239-248

  Panjari, M ^a   Davis, Susan R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Central and Eastern Clinical School   (Australia)

Author keywords

Androgen therapy; DHEA; DHEAS; Sexual function

Indexed keywords

ANDROGEN; ESTROGEN; HUMAN GROWTH HORMONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; IMMUNOLOGICAL ADJUVANT;

ADRENAL INSUFFICIENCY; AGE; ANXIETY DISORDER; BECK DEPRESSION INVENTORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG CLEARANCE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENERGY METABOLISM; ESTROGEN THERAPY; EXHAUSTION; FEMALE; HUMAN; HYPOPITUITARISM; LIBIDO; LIBIDO DISORDER; MENOPAUSAL SYNDROME; MENTAL HEALTH; MOOD; MUSCLE RELAXATION; NONHUMAN; PHYSICAL DEVELOPMENT; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SELF ESTEEM; SEXUAL FUNCTION; SEXUALITY; SINGLE DRUG DOSE; SLEEP PATTERN; STRESS MANAGEMENT; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; WELLBEING; DRUG EFFECT; METHODOLOGY; SEXUAL DYSFUNCTION; WOMEN'S HEALTH;

ADJUVANTS, IMMUNOLOGIC; DEHYDROEPIANDROSTERONE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUALITY; WOMEN'S HEALTH;

EID: 33947603022     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dml055     Document Type: Review

References (55)

1. Arlt W (2004) Dehydroepiandrosterone replacement therapy. Semm Reprod 22,379-388.
2. Arlt W and Allolio B (2003a) Adrenal insufficiency. [see comment). Lancet 361,1881-1893.
3. Arlt W and Allolio B (2003b) DHEA replacement in adrenal insufficiency [comment]. J Clin Endocrinol Metab 88,4001; author reply 4001-4002.
4. Arlt W, Callies F, Van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M and Schulte H et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Eng J Med 341,1013-1020.
5. Auchus RJ (2004) Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 22,281-288.
6. Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S and Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84,3896-3902.
7. Baulieu EE (1996) Dehydroepiandrosterone (DHEA): A fountain of youth? J Clin Endocrinol Metabo 81,3147-3151.
8. Baulieu. E, Thomas G. Legrain S, Roger M, Debuire B, Faucounau V, Girard L, Hervy M, Latour F and Leaud M et al. (2000) Dehydroepiandrosterone (DHEA), DBEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci 97,4279-4284.
9. Bloch M, Schmidt PJ, Danaceau MA, Adams, LF and Rubinow DR (1999) Dehydroepiandrosterone treatment of midlife dysthymia. [see comment]. Biol Psychiatry 45,1533-1541.
10. Bulun SE and Simpson ER (1994) Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab 78,428-432.
11. Burger HG (2W2) Androgen production in women. Fertil Steril 77 (Suppl 4),S3-S5.
12. Burger HG, Dudley EC, Cui J, Dennerstein L and Hopper JL (2000) A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metabo 85,2832-2838.
13. Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hamby PJ, Abraham G and Buster JE (1998) Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density hpoprotein: A six-month trial. Fertil Steril 70,107-110.
14. Chen F, Knecht K, Birzin E, Fisher J, Wilkinson H, Mojena M, Moreno CT, Schmidt A, Harada SI and Freedman LP et al. (2005) Direct agonist/ antagonist functions of dehydroepiandrosterone (DHEA). Endocrinology 146,4568-4576.
15. Davis S, Davison S, Donath S and Bell R (2005) Circulating Androgen Levels and Self-reported Sexual Function in Women. JAMA 294,91-96.
16. Davison SL, Bell R. Donath S, Montalto JG and Davis SR (2005) Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90,3847-3853.
17. Dean CE (2000) Prasterone (DHEA) and mania. Ann Pharmacother 34,1419-1422.
18. Dunn JF, Nisula BC and Rodboard D (1981) Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and cortico-steroid-binding globulin in human plasma, J Clin Endocrinol Metab 53,58-68.
19. Hackbert L and Heiman J (2002) Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 11,155-162.
20. Haning JRV, Hackett R, Flood CA, Loughlin J, Zhao Q and Longcope C (1993) Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 76,1301-1307.
21. Havelock JC, Auchus RJ and Rainey WE (2004) The rise in adrenal androgen biosynthesis: Adrenarche. Semin Reprod Med 22,337-347.
22. Hunt P, Gumell E and Huppert F (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85,4650-4656.
23. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA and Karlsson FA (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: A placebo-controlled trial. J Clin Endocrinol Metab 87,2046-2052.
24. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ and Frye RF (1999) DHEA and DHEA-S: A review. J Clin Pharmacol 39,327-348.
25. Kumar A, Woods KS, Bartolucci AA and Azziz R (2005) Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 62,644.
26. Labrie F (1991) Intracrinology. Mol Cell Endocrinol 78,C113-C118.
27. Labrie F (2003) Extragonadal synthesis of sex steroids: Intracrinology. Annales d Endocrinologie 64,95-107.
28. Labrie F (2004) Adrenal androgens and intracrinology [see comment]. Semin Reprod Med 22,299-309.
29. Labrie C, Belanger A and Labrie F (1988) Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123,1412-1417.
30. Labrie F, Belanger A, Cusan L and Candas B (1997a) Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology. J Clin Endocrinol Metab 82,2403-2409.
31. Labrie F, Belanger A, Cusan L, Gomez J-L and Candas B (1997b) Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated andrgoen metaboliltes during aging. J Clin Endocrinol Metab 82,2396-2402.
32. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL and Candas B (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: Its role during aging. Steroids 63,322-328.
33. Labrie F, Luu-The V, Labrie C and Simard J (2001) DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology. Front Neuroendocrinol 22,185-212.
34. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX and Pelletier G (2003) Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocrine Rev 24,152-182.
35. Liu D and Dillon JS (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem 277,21379-2188.
36. Liu D and Dillon JS (2004) Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: Evidence for a cell surface receptor. Steroids 69,279-289.
37. Lobo R (1984) The role of the adrenal in polycystic ovary syndrome. Semin Reprod Endocrinol 2,251-262.
38. Lovas K, Gebre-Medhin G, Trovik T, Fougner K, Uhlving S, Nedrobo B, Myking O, Kampe O and Husebye E (2003) Replacement of dehydroepiandrosterone in adrenal failure: No benefit for subjective health status and sexuality in a 9-month randomized parallel group clinical trial. J Clin Endocrinol Metab 88,1112-1118.
39. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL and Daynes RA (1992) The presence of a dehydo-epiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42,293-304.
40. Meston CM and Heiman JR (2002) Acute dehydroepiandrosterone effects on sexual arousal in premenopausal women. J Sex Marital Ther 28,53-60.
41. Misso ML, Jang C, Adams J, Tran J, Murata Y, Bell R, Boon WC, Simpson ER and Davis SR (2005) Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12,210-215.
42. Morales AJ, Nolan JJ, Nelson JC and Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. Erratum appears in J Clin Endocrinol Metab 1995;80(9);2799. J Clin Endocrinol Metab 78,1360-1367.
43. Mortola JF and Yen SS (1990) The effects of oral dehydroepiandrosterone on Endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 71,696-704.
44. Parasrampuria J, Schwartz K and Petesch R (1998) Quality control of dehydroepiandrosterone dietary supplement products. JAMA 280,1565.
45. Payne AH and Hates DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Rev 25,947-970.
46. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N and Rubinow DR (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62,154-62.
47. van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B and Smit JW (2005) Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: A randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90,3295-3303.
48. Vermeulen A and Ando S (1978) Prolactin and adrenal androgen secretion. Clin Endocrinol (Oxf) 8,295-303.
49. van Vollenhoven RF (2002) Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 3,23-31
50. Widstrom RL and Dillon JS (2004) Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate? Semin Reprod Med 22,289-298.
51. Williams MR, Dawood T, Ling S, Dai A, Lew R, Myles K, Funder JW, Sudhir K and Komesaroff PA (2004) Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab 99,4708-4715.
52. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, Pirke KM and Kirschbaum C (1997) Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82,2363-2367.
53. Wolkowitz OM, Reus VI, Koehler A, Nelson N, Friedland M. Brizendine L and Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156,646-649.
54. Zapata E, Ventura JL, De la Cruz K, Rodriguez E, Damian P, Masso F, Montano LF and Lopez-Marure R (2005) Dehydroepiandrosterone inhibits the proliferation of human umbilical vein endothelial cells by enhancing the expression of p53 and p2l, restricting the phosphorylation of retinoblastoma protein, and is androgen- and estrogen-receptor independent. FEBS J 272,1343-1353.
55. Zumoff B, Rosenfeld RS and Strain GW (1980) Sex differences in the 24 hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 51,330-334.